| Heather Lowrie, PHARMD | |
|
212 S Summit St, Arkansas City, KS 67005-2847 | |
| (620) 442-2300 | |
| (620) 442-9498 |
| Full Name | Heather Lowrie |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 212 S Summit St, Arkansas City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487363818 | NPI | - | NPPES |
| 1-107671 | Other | KS | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-107617 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Lowrie, PHARMD 212 S Summit St, Arkansas City, KS 67005-2847 Ph: (620) 442-2300 | Heather Lowrie, PHARMD 212 S Summit St, Arkansas City, KS 67005-2847 Ph: (620) 442-2300 |
News Archive
ABC News: "Summoning the message back that once mobilized his grass-roots campaign, the president spoke tonight in front of the same people - Organizing for America and DNC members - whose poll show some are feeling somewhat discouraged by the first year of the Obama administration. ... The president outlined in broad strokes what he'd like to see happen [on health reform]. 'What I'd like to do is have a meeting where I'm sitting with the Republicans, sitting with the Democrats.
Three in five teenagers surveyed by the British Skin Foundation reported ‘a fall in self-confidence' as the biggest impact that acne has on their lives. From my experience as a dermatologist I find that those with acne can often feel unsupported, socially isolated and become withdrawn.
The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis.
A bird flu vaccine for humans could be only months away since the success of a vaccine on monkeys in Vietnam, researchers hope to have a vaccine ready for testing in humans later this year.
Schering-Plough Corporation (NYSE:SGP) today announced that the European Commission and the US FDA both approved the intravenous (IV) formulation of temozolomide as an alternative to the already approved oral form of the drug.
› Verified 5 days ago
Erica Tackett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2701 N Summit St, Arkansas City, KS 67005 Phone: 620-442-2051 | |
Koffi Kolagbe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 N Summit St, Arkansas City, KS 67005 Phone: 620-442-7842 | |
Meagan Mason, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 N Summit St, Arkansas City, KS 67005 Phone: 620-441-0283 Fax: 620-441-0887 | |
Amber Dawn Moore, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 N Summit St, Arkansas City, KS 67005 Phone: 620-441-0283 Fax: 620-441-0887 | |
Karen Kay Pontius, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 S Summit St, Arkansas City, KS 67005 Phone: 620-442-3500 | |
Megan Marie Mangrum, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 N Summit St, Arkansas City, KS 67005 Phone: 620-442-7842 |